Table 15.

Recommendations for the management of hypertension with heart failure. BP: blood pressure; CCB: calcium channel blockers; RAS: reninangiotensin system.

Class	Recommendation
	BP-lowering treatment is recommended for all people with heart failure and stage 2 hypertension (BP>140/90 mmHg). Treatment threshold and target values recommended for the general population are the same for people with heart failure with reduced or preserved ejection fraction (<130mmHg but preferably not lower than 120mmHg).
	Treatment including a RAS blocker, and a beta-blocker and diuretic and/or mineralocorticoid receptor antagonists (if required) is recommended for people with heart failure and reduced ejection fraction.
	a RAS blocker in combination with a CCB or diuretic is recommended for people with left ventricular hypertrophy.
	Diuretics should be included in the management of people with heart failure and volume overload.
	Dihydropyridine CCBs may be considered in case treatment target is not achieved.
	Nonhydropyridine CCBs are not recommended in the treatment of people with heart failure and reduced ejection fraction.